So the real question is what would-be manufacturers of biogenerics will be required to do to win approval here.

所以真正的问题是那些希望成为非专利生物技术药物生产者的公司需要做出努力来赢得当局者的允许。

youdao

So the real question is what would-be manufacturers of biogenerics will be required to do to win approval here.

所以真正的问题是那些希望成为非专利生物技术药物生产者的公司需要做出努力来赢得当局者的允许。

youdao